Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
Status:
RECRUITING
Trial end date:
2029-05-31
Target enrollment:
Participant gender:
Summary
This study will apply novel MRI approaches with established sensitivity to tissue oxygen consumption and perfusion to predict hypoxia-associated radiation resistance, manifested as tumor recurrence and progression post-treatment.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborator:
National Institutes of Health (NIH)
Treatments:
fluoromisonidazole Magnetic Resonance Spectroscopy